The Impact of Digital Pathology in Drug Development and the Potential of AI in Healthcare

Jacob sits down with PathAI Ceo Dr. Andy Beck to discuss the state of AI adoption in diagnosis, why Path acquired their own lab, pathologists' jobs in the future and nailing GTM to reach a ~$1B valuation. 

00:00 intro 

01:01 pathology and AI 

13:30 nailing go-to-market strategy 

19:47 how pathology labs can go digital 

25:36 regulatory frameworks and roadblocks 

33:05 do improvements in foundation models impact PathAI? 

36:26 standardizing diagnoses 

40:05 how will the job of a pathologist change going forward? 

42:35 NASH 

47:30 working in Daphne Koller’s lab